| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals, Inc. (AMLX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AMLX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.32M | $51.99M | - | |
| CEO | 3.32M | $51.99M | - | |
| Dir | 812.9K | $12.74M | - | |
| CFO | 177.1K | $2.78M | - | |
| Other | 175.8K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Mazzariello Gina53 | Chief Legal Officer | Sell | 4,169 | $3.15 | $13,144.86 | -3.0% | +57.6% | +391.2% | |
| Feb 3, 2025 | Mazzariello Gina53 | Chief Legal Officer | Sell | 3,678 | $3.49 | $12,839.16 | -2.6% | +50.6% | +323.7% | |
| Feb 3, 2025 | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 11,851 | $3.47 | $41,107.56 | -0.4% | +50.6% | +323.7% | |
| Feb 3, 2025 | Klee Justin B.60 | Co-chief Executive Officer | Sell | 11,855 | $3.47 | $41,103.66 | -0.4% | +50.6% | +323.7% | |
| Jan 6, 2025 | Klee Justin B.60 | Co-chief Executive Officer | Sell | 7,471 | $4.04 | $30,201.52 | -0.2% | -11.7% | +190.3% | |
| Jan 6, 2025 | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 7,471 | $4.05 | $30,232.15 | -0.2% | -11.7% | +190.3% | |
| Dec 2, 2024 | Bedrosian Camille L64 | Chief Medical Officer | Sell | 5,421 | $5.54 | $30,007.40 | -3.8% | -45.9% | +147.7% | |
| Sep 30, 2024 | Klee Justin B.60 | Co-chief Executive Officer | Sell | 18,589 | $3.20 | $59,429.03 | -0.6% | +18.5% | +319.4% | |
| Sep 30, 2024 | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 18,589 | $3.20 | $59,414.16 | -0.6% | +18.5% | +319.4% | |
| Sep 30, 2024 | Bedrosian Camille L64 | Chief Medical Officer | Sell | 11,442 | $3.20 | $36,559.48 | -7.4% | +18.5% | +319.4% |